4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001144204-12-039996
SVP, Product Development acquired 185,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Almon Einat Brill SVP, Product Development | 2012-07-16 | Grant or award | +185,000 | 185,000 | I |
Loading xslF345X03/v318897_4.xml…